Featured Research

from universities, journals, and other organizations

Possible new heritable marker for retinoblastoma

Date:
February 3, 2010
Source:
Sbarro Health Research Organization
Summary:
Researchers have shed light on the possible role of inactivation of the 16INK4A gene in the progression of retinoblastoma.

Retinoblastoma is a pediatric eye cancer initiated by the loss or mutation of both copies of the retinoblastoma gene. Current evidence suggests that additional genetic alterations are required for retinoblastoma to become fully malignant.

Related Articles


Researchers working at the Sbarro Institute for Cancer Research and Molecular Medicine at Temple University in Philadelphia, PA and at the University of Siena in Siena, Italy, have shed light on the possible role of inactivation of the 16INK4A gene in the progression of retinoblastoma. Their study results appear in the latest edition of the Journal of Cellular Physiology.

"The finding that the expression of p16INK4A was reduced both in patients and their parents in our samples suggests that this alteration could be a novel marker of an inheritable susceptibility to retinoblastoma in young patients," said Antonio Giordano, M.D Ph.D., director of the Sbarro Institute and the Center for Biotechnology at Temple, the lead author of the study.

Researchers chose to investigate the 16INK4A gene because of its suspected role in the development of retinoblastoma, as well as its involvement in a predisposition to familial cancer.

The study examined blood samples taken from 29 patients and their parents. They found low to moderate 16INK4A protein expression in 5 of 11 (45%) retinoblastoma tumor specimens. They also found reduced p16INK4a RNA expression in blood, correlated with the demethylation, or reduction, of the p16INK4a gene, in 16 of 29 (55%) of retinoblastoma patients relative to normal controls.

"Intriguingly, the researchers also found reduced expression in at least one parent among 9 of the 16 (56%) patients with reduced p16INK4a RNA expression. Dr. Giordano and his coworkers suggest that this finding could represent a marker for retinoblastoma susceptibility," said Joan O'Brien, Chair of the Department of Ophthalmology at the University of Pennsylvania and Director of the Scheie Eye Institute. "Confirmation of this hypothesis by future studies would enhance our understanding of genetic and epigenetic events contributing to this disease."


Story Source:

The above story is based on materials provided by Sbarro Health Research Organization. Note: Materials may be edited for content and length.


Cite This Page:

Sbarro Health Research Organization. "Possible new heritable marker for retinoblastoma." ScienceDaily. ScienceDaily, 3 February 2010. <www.sciencedaily.com/releases/2010/01/100126175825.htm>.
Sbarro Health Research Organization. (2010, February 3). Possible new heritable marker for retinoblastoma. ScienceDaily. Retrieved October 25, 2014 from www.sciencedaily.com/releases/2010/01/100126175825.htm
Sbarro Health Research Organization. "Possible new heritable marker for retinoblastoma." ScienceDaily. www.sciencedaily.com/releases/2010/01/100126175825.htm (accessed October 25, 2014).

Share This



More Health & Medicine News

Saturday, October 25, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

IKEA Desk Converts From Standing to Sitting With One Button

IKEA Desk Converts From Standing to Sitting With One Button

Buzz60 (Oct. 24, 2014) IKEA is out with a new convertible desk that can convert from a sitting desk to a standing one with just the push of a button. Jen Markham explains. Video provided by Buzz60
Powered by NewsLook.com
Ebola Protective Suits Being Made in China

Ebola Protective Suits Being Made in China

AFP (Oct. 24, 2014) A factory in China is busy making Ebola protective suits for healthcare workers and others fighting the spread of the virus. Duration: 00:38 Video provided by AFP
Powered by NewsLook.com
WHO: Millions of Ebola Vaccine Doses by 2015

WHO: Millions of Ebola Vaccine Doses by 2015

AP (Oct. 24, 2014) The World Health Organization said on Friday that millions of doses of two experimental Ebola vaccines could be ready for use in 2015 and five more experimental vaccines would start being tested in March. (Oct. 24) Video provided by AP
Powered by NewsLook.com
Doctor in NYC Quarantined With Ebola

Doctor in NYC Quarantined With Ebola

AP (Oct. 24, 2014) An emergency room doctor who recently returned to the city after treating Ebola patients in West Africa has tested positive for the virus. He's quarantined in a hospital. (Oct. 24) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins